SCHEMBL12412504

SCHEMBL12412504

C=Cc1ccc(C(=O)C(O)c2cc(OC)cc(OC)c2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.44
RXRA P19793 1/20 0.40
TAS1R3 Q7RTX0 2/20 0.39
TAS1R1 Q7RTX1 2/20 0.39
NQO2 P16083 2/20 0.39
PDE4A P27815 3/20 0.39
PDE4B Q07343 3/20 0.39
PDE4C Q08493 3/20 0.39
PDE4D Q08499 3/20 0.39
F3 P13726 1/20 0.39
ALDH1A1 P00352 2/20 0.38
CYP1A2 P05177 2/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12412505 0.85 CES2 (0.41) ABCG2ALDH1A1MEN1NPC1RAB9A
Acrylic Acid SCHEMBL10353178 0.83 CES2 (0.50) PDE4APDE4BPDE4CPDE4DALDH1A1
SCHEMBL139044 0.81 CES2 (0.59) RXRAALDH1A1MEN1NPC1GAA
SCHEMBL14181968 0.81 CES2 (0.48) ABCG2RXRAPDE4APDE4BPDE4C
Carbamic Acid SCHEMBL23407287 0.81 CA1 (0.50) RXRAPDE4APDE4BPDE4CPDE4D
Bicarbonate SCHEMBL291493 0.80 CES2 (0.58) RXRAALDH1A1MEN1NPC1GAA
SCHEMBL3757038 0.79 CES2 (0.55) TAS1R3TAS1R1ALDH1A1CES2LMNA
Acetic Acid SCHEMBL3368380 0.79 CES2 (0.56) ALDH1A1MEN1NPC1CYP3A4GAA
SCHEMBL12412503 0.78 ELANE (0.49) RXRANQO2PDE4APDE4BPDE4C
Carbamic Acid SCHEMBL1695357 0.78 CES2 (0.54) ALDH1A1MEN1NPC1GAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160136286-A1 DRUG DELIVERY COMPOSITION THE QUEEN'S UNIVERSITY OF BELFAST (GB) 2016-05-19 US disclosed
US-20160136286-A1 DRUG DELIVERY COMPOSITION THE QUEEN'S UNIVERSITY OF BELFAST (GB) 2016-05-19 US disclosed
US-9271928-B2 Drug delivery composition THE QUEEN'S UNIVERSITY OF BELFAST (GB) 2016-03-01 US disclosed
US-9271928-B2 Drug delivery composition THE QUEEN'S UNIVERSITY OF BELFAST (GB) 2016-03-01 US disclosed
US-20110165114-A1 DRUG DELIVERY COMPOSITION QUEEN'S UNIVERSITY OF BELFAST, THE (GB) 2011-07-07 US disclosed
US-20110165114-A1 DRUG DELIVERY COMPOSITION QUEEN'S UNIVERSITY OF BELFAST, THE (GB) 2011-07-07 US disclosed
WO-2009147372-A2 DRUG DELIVERY COMPOSITION THE QUEEN'S UNIVERSITY OF BELFAST (GB) 2009-12-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110165114-A1 DRUG DELIVERY COMPOSITION ECPAS, ABCB11, ABCB1 ABCG2 49/4885RXRA 765/4885TAS1R3 4856/4885
US-20160136286-A1 DRUG DELIVERY COMPOSITION ECPAS, ABCB11, ABCB1 ABCG2 49/4885RXRA 765/4885TAS1R3 4856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.